Dexcom shares plunge more than 40% after Q2 earnings

Dexcom shares sank more than 40% on Friday, their steepest decline ever, after the diabetes management company reported disappointing revenue for the second quarter and offered weak guidance. The stock fell $43.85 to close at $64, wiping out more than…





